Biosimilars India 2010

With an estimated $25 billion of biologics coming off patent imminently, biosimilars present the pharma industry with most lucrative market opportunity for a long time. The pharma, biotechnology, CRO, and CMO organisations who prepare themselves today will reap the enormous biosimilars rewards tomorrow.

CPhI Conferences is delighted to present its 2nd Annual Biosimilars India 2010 conference. This two-day strategic event will provide all the key players within the biosimilars value chain with the opportunity to assess the market, determine the right technical strategy, and drive the development and registration of biosimilars products both here in India and overseas.

Teresa Rea will speak at this event.